Ceftriaxone CAS:73384-59-5
Ceftriaxone is prescribed by healthcare providers for the treatment of various infections, including pneumonia, urinary tract infections, meningitis, septicemia, gonorrhea, and Lyme disease. The dosage and duration of ceftriaxone therapy depend on the type of infection, its severity, and patient-specific factors. Patients typically receive ceftriaxone through intravenous or intramuscular administration under medical supervision to ensure proper dosing and monitoring of treatment response. Adherence to the prescribed dosing schedule and completion of the full course of treatment are crucial to effectively clear the infection and prevent recurrence. While generally well-tolerated, potential side effects of ceftriaxone may include gastrointestinal disturbances, allergic reactions, or injection site reactions. Patients should be monitored for any adverse reactions during treatment, and any severe or persistent side effects should be reported to a healthcare provider for evaluation and management. Ceftriaxone plays a significant role in clinical settings as a potent antibiotic option for treating bacterial infections when utilized appropriately under medical guidance.
Composition | C18H18N8O7S3 |
Assay | 99% |
Appearance | white powder |
CAS No. | 73384-59-5 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |